RecruitingNot ApplicableNCT05788666

Use of GeriKit to Better Phenotype Older Adults With Ischemic Heart Disease


Sponsor

NYU Langone Health

Enrollment

150 participants

Start Date

Jan 18, 2024

Study Type

INTERVENTIONAL

Conditions

Summary

This study seeks to expand the use of the NYU GeriKit mobile application ("app") in a diverse range of settings to better phenotype older patients, which will enhance both research and patient care.


Eligibility

Min Age: 75 YearsMax Age: 100 Years

Inclusion Criteria4

  • Age ≥ 75
  • Currently hospitalized for acute mycardial infarction (AMI), percutaneous coronary intervention (PCI), or coronary artery bypass grafting (CABG); or hospitalized for AMI, PCI, or CABG within the prior 4 weeks
  • Capable of self-consent
  • Understand and are able to perform study procedures in English

Exclusion Criteria6

  • Non-ambulatory
  • Moderate or severe cognitive impairment (operationalized as known diagnosis of dementia)
  • Unable or unwilling to consent
  • Incarcerated
  • Unable to use complete assessments in English
  • Unable to complete geriatric assessment for other reasons

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

PROCEDUREGeriKit Mobile Application

Digital health app used for comprehensive geriatric assessment (CGA). The app includes a series of brief, well-validated instruments: the MiniCog, 30-Second Chair Stand, Activities of Daily Living, Instrumental Activities of Daily Living, Patient Health Questionnaire (PHQ-9), Mini Nutrition Assessment, 2-Item Fall Screen, and Polypharmacy screen.


Locations(1)

NYU Langone Health

New York, New York, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05788666


Related Trials